Navco Pharmaceuticals Inc.
NAV.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.70K | -57.00K | -670.90K | -792.50K | -1.07M |
| Total Depreciation and Amortization | 500.00 | 1.00K | -27.80K | -2.30K | 17.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.40K | 6.90K | 574.20K | 333.00K | 658.20K |
| Change in Net Operating Assets | 29.70K | 33.90K | 93.10K | 420.90K | 321.00K |
| Cash from Operations | -16.30K | -15.40K | -31.70K | -41.10K | -77.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 22.00K | 22.00K | 49.00K | 67.70K | 45.70K |
| Total Debt Repaid | 0.00 | -5.00K | -10.00K | -13.70K | -18.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.30K | 11.70K | 27.80K | 38.80K | 19.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | -1.00K | -3.70K | -3.80K | -2.20K | -57.70K |